Dorian Therapeutics is the leading company working on senoblockers, a new class of therapeutics that can rejuvenate cells and tissues. Based on a patented technology developed at Stanford University, Dorian’s team is bringing to the clinic an innovative solution for age-associated diseases.

The Problem: Aging

There is one common risk factor for the majority of diseases in the developed world: aging.

 

At Dorian, we are rethinking how to address these unmet medical needs and we have found our answer in the biology of aging.

joel-filipe-GVV669GVYjo-unsplash-min.jpg

DORIAN THERAPEUTICS

Younger, for longer.

LongBump_FINAL.png
LongBump_FINAL.png

The Solution:

 Senoblockers

During aging, there is a decrease in the activity of stem cells, and therefore a reduced regenerative capacity. Additionally, senescent cells accumulate in the body and poison entire tissues.

Dorian's Senoblockers act on epigenetic regulators to reverse both processes, reactivating programs of youthfulness and regeneration.

Asset 1@4x.png
 
LongBump_FINAL.png
LongBump_FINAL.png
 

OUR COMMUNITIES

To play, press and hold the enter key. To stop, release the enter key.